At a glance
ClinicalIndex Comparison RecordN/ATerminated· 8 enrolled
Drug / intervention
Marine Lipid Oil Concentrate +3 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of a Specialized Pro-Resolving Mediator Formulation on Inflammation in Individuals Who Are Overweight to Mildly Obese and Otherwise Generally Healthy
In Brief
A clinical study evaluating Marine Lipid Oil Concentrate, Dietary Supplement, and 1 other intervention for Inflammation and Inflammatory Response. Terminated early, enrolled 8 participants across 1 site.
Signals
Trial was terminated early
Detailed Summary
To assess the efficacy and safety of a Marine Lipid Oil Concentrate formulation on inflammatory biomarkers and overall well-being in male and female subjects who are overweight to mildly obese, but otherwise generally healthy.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInflammation, Inflammatory Response
CountriesUnited States
Collaborators--
Timeline
N/ATerminatedFinished
2020202120222023202420252026
Enrollment StartOct 2019
First PostedFeb 2020
Primary CompletionSep 2021
TodayJul 2026
First PostedFeb 17, 2020
Enrollment StartOct 31, 2019
Primary CompletionSep 30, 2021
TodayJul 1, 2026
Enrollment to primary: 1.9 yearsPosted 6.4 years ago
Interventions
Marine Lipid Oil Concentratedietary
Marine Lipid Oil Concentrate softgels
Dietary Supplementdietary
Dietary Supplement capsules
Placebodietary
Placebo softgels
Placebodietary
Placebo capsules